PharmaShots | Incisive News in 3 Shots

Subscribe Now

Efficacy

Russia's Sputnik V Demonstrates 92% Efficacy Against COVID-19

Russia's Sputnik V Demonstrates 92% Efficacy Against COVID-19

February 3, 2021

AstraZeneca Reports Long-Term Efficacy and Tolerability of Calquence (acalabrutinib) in P-ll ACE-LY-004 Study for MCL

AstraZeneca Reports Long-Term Efficacy and Tolerability of Calquence (acalabrutinib) in P-ll ACE-LY-004 Study for MCL

December 7, 2020

Pfizer and BioNTech's BNT162b2 Demonstrates 95% Efficacy in Preventing COVID-19

Pfizer and BioNTech's BNT162b2 Demonstrates 95% Efficacy in Preventing COVID-19

November 19, 2020

AstraZeneca Reports Pooled Cardiovascular Safety and Efficacy Analyses of Roxadustat in P-III Program for CKD Patients with Anaemia

AstraZeneca Reports Pooled Cardiovascular Safety and Efficacy Analyses of Roxadustat in P-III Program for CKD Patients with Anaemi...

November 11, 2019

Amgen Reports Safety & Efficacy Results of Repatha (evolocumab) in OSLER-1 Five-Year Extension Study

Amgen Reports Safety & Efficacy Results of Repatha (evolocumab) in OSLER-1 Five-Year Extension Study

November 13, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us